FSTL1 and obstructive sleep apnea syndrome: This comes in agreement with our data emphasizing that OSA severity, which is mediated through IH, may inhibit FSTL1 expression, hence reducing its beneficial activities in mitigating hypoxia-driven cellular damage and inflammation.